(Q27691456)

Werth VP

series ordinal

2

1 reference

Parisi E

series ordinal

3

1 reference

Sollecito TP

series ordinal

4

1 reference

publication date

October 2013

1 reference

Dental clinics of North America

published in

1 reference

volume

57

1 reference

issue

4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

page(s)

611-30

1 reference

1 reference

Critical analysis of the use of rituximab in mucous membrane pemphigoid: a review of the literature

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Mucous membrane pemphigoid: recent advances

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Incidence, presenting features, and diagnosis of cicatrising conjunctivitis in the United Kingdom

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Low-level laser therapy for oral mucous membrane pemphigoid.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Biologics in oral medicine: principles of use and practical considerations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Therapeutic approaches to patients with mucous membrane pemphigoid

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Validation of a fornix depth measurer: a putative tool for the assessment of progressive cicatrising conjunctivitis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Early onset childhood cicatricial pemphigoid: a case report and review of the literature

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Prevention and treatment of systemic glucocorticoid side effects

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Low-level laser therapy in the treatment of mucous membrane pemphigoid: a promising procedure

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Laryngeal mucous membrane pemphigoid: a systematic review and pooled-data analysis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Cyclosporine for ocular inflammatory diseases

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Transscleral diode laser cyclophotocoagulation in a patient with ocular cicatricial pemphigoid

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Methotrexate for ocular inflammatory diseases

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

T-helper 17 lymphocytes in ocular cicatricial pemphigoid

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Off-label use of biologicals in the management of inflammatory oral mucosal disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Coexistent psoriasis and bullous pemphigoid responding to mycophenolate mofetil monotherapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Oral pemphigoid autoantibodies preferentially target BP180 ectodomain

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Ocular autoimmune pemphigoid and cyclosporin A.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Mucous membrane pemphigoid and pseudopemphigoid

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Antiepiligrin cicatricial pemphigoid of the larynx successfully treated with a combination of tetracycline and niacinamide

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Autoantibodies to human alpha6 integrin in patients with oral pemphigoid

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Drug-induced blistering oral lesions

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Drug-induced cicatricial pemphigoid and acquired epidermolysis bullosa

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Immunopathology of oral mucosal ulcerative, desquamative, and bullous diseases. Selective review of the literature

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Adhesion molecules. II: Interactions of keratinocytes with epidermal basement membrane

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Cicatricial pemphigoid in a four-year-old child: A case report

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Dapsone therapy of cicatricial pemphigoid.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Association of DQw7 (DQB1*0301) with ocular cicatricial pemphigoid

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Cicatricial pemphigoid in a young girl: report of a case

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Recalcitrant cicatricial pemphigoid treated with the anti-TNF-alpha agent etanercept.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Cimetidine improves the therapeutic/toxic ratio of dapsone in patients on chronic dapsone therapy

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Studies of cicatricial pemphigoid autoantibodies using direct immunoelectron microscopy and immunoblot analysis

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Visual improvement after cultivated oral mucosal epithelial transplantation

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Ocular and oral grading of mucous membrane pemphigoid.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Rituximab for patients with refractory mucous membrane pemphigoid.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

A rare unilateral case of ocular mucous membrane pemphigoid

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Multiple mucosal involvement in cicatricial pemphigoid.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

The use of rituximab in refractory mucous membrane pemphigoid with severe ocular involvement.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Successful treatment of mucous membrane pemphigoid with the anti-CD-20 antibody rituximab.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Topical tacrolimus for oral cicatricial pemphigoid

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Ocular cicatricial pemphigoid, keratomycosis, and intravenous immunoglobulin therapy

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Profile of autoantibody to basement membrane zone proteins in patients with mucous membrane pemphigoid: long-term follow up and influence of therapy

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Mucous membrane pemphigoid: a dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Localized cicatricial pemphigoid of the Brunsting-Perry type with transition into disseminated cicatricial pemphigoid. Report of a case proved by preembedding immunogold electron microscopy.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3928007

Significantly increased occurrence of HLA-DQB1*0301 allele in patients with ocular cicatricial pemphigoid

27 November 2018

1 reference

12 December 2020

Cicatricial pemphigoid successfully treated with pulse intravenous cyclophosphamide

1 reference

12 December 2020

Adhesion molecules and oral mucosal diseases

1 reference

12 December 2020

Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid

1 reference

12 December 2020

Limbal conjunctival Langerhans cell density in ocular cicatricial pemphigoid: an indirect immunofluorescence study on Dispase-split conjunctiva

1 reference

12 December 2020

Combination therapy with nicotinamide and tetracyclines for cicatricial pemphigoid: further support for its efficacy

1 reference

12 December 2020

Mucosal morbidity in patients with epidermolysis bullosa acquisita

1 reference

12 December 2020

A retrospective study of the management of oral mucous membrane pemphigoid with dapsone

1 reference

12 December 2020

Analysis of Antigens Targeted by Circulating IgG and IgA Antibodies in Patients With Mucous Membrane Pemphigoid Predominantly Affecting the Oral Cavity

1 reference

12 December 2020

Mucous membrane pemphigoid

1 reference

12 December 2020

Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity

1 reference

12 December 2020

Successful treatment of mucous membrane pemphigoid with tacrolimus

1 reference

12 December 2020

Antigen specificity in subsets of mucous membrane pemphigoid

1 reference

12 December 2020

Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients

1 reference

12 December 2020

Treatment of ocular cicatricial pemphigoid with the tumour necrosis factor alpha antagonist etanercept

1 reference

12 December 2020

Humanization of autoantigen

1 reference

12 December 2020

Intravenous immunoglobulins and mucous membrane pemphigoid

1 reference

12 December 2020

The management of oral mucous membrane pemphigoid with dapsone and topical corticosteroid

1 reference

12 December 2020

Cyclophosphamide and amniotic membrane transplantation in the management of ocular disease in a case of antiepiligrin cicatricial pemphigoid

1 reference

12 December 2020

Human anti-laminin 5 autoantibodies induce subepidermal blisters in an experimental human skin graft model

1 reference

12 December 2020

[Ocular cicatricial pemphigoid. Retrospective analysis of risk factors and complications]

1 reference

12 December 2020

Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations

1 reference

12 December 2020

Treatment of cicatricial pemphigoid with pulse intravenous cyclophosphamide

1 reference

12 December 2020

Mucous membrane pemphigoid: HLA-DQB1*0301 is associated with all clinical sites of involvement and may be linked to antibasement membrane IgG production

1 reference

12 December 2020

Mucous membrane pemphigoid

1 reference

12 December 2020

Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180

1 reference

12 December 2020

Combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid: a preliminary report

1 reference

12 December 2020

Coexisting bullous pemphigoid and psoriasis successfully treated with etanercept

1 reference

12 December 2020

Generating consensus research goals and treatment strategies for pemphigus and pemphigoid: The 2010 JC Bystryn Pemphigus and Pemphigoid Meeting

1 reference

12 December 2020

Rituximab for severe mucous membrane pemphigoid: safe enough to be drug of first choice?

1 reference

12 December 2020

Rituximab for treatment-refractory pemphigus and pemphigoid: A case series of 17 patients

1 reference

12 December 2020

Oral mucous membrane pemphigoid: complete response to topical tacrolimus

1 reference

12 December 2020

Cicatricial pemphigoid of the scalp mimicking discoid lupus erythematosus

1 reference

12 December 2020

Long-term results of therapy with mycophenolate mofetil in ocular mucous membrane pemphigoid

1 reference

12 December 2020

Therapeutic effect of etanercept in anti-laminin 5 (laminin 332) mucous membrane pemphigoid

1 reference

12 December 2020

Treatment of mucous membrane pemphigoid with the combination of mycophenolate mofetil, dapsone, and prednisolone: a case series

1 reference

12 December 2020

Treatment of recalcitrant cicatricial pemphigoid with the tumor necrosis factor alpha antagonist etanercept

1 reference

12 December 2020

Methotrexate therapy for ocular cicatricial pemphigoid

1 reference

12 December 2020

Vitamin E and dapsone-induced hemolysis

1 reference

12 December 2020

Cicatricial pemphigoid

1 reference

12 December 2020

Cicatricial pemphigoid

1 reference

12 December 2020

Vegetating cicatricial pemphigoid. A new subset of the cicatricial pemphigoid spectrum

1 reference

12 December 2020

Systemic chemotherapy for ocular cicatricial pemphigoid

1 reference

12 December 2020

Cutaneous manifestations of cryoglobulinemia: clinical and histopathologic study of seventy-two patients

1 reference

12 December 2020

Improved detection of disease progression in ocular cicatricial pemphigoid

1 reference

12 December 2020

The conjunctiva in acute and chronic mucous membrane pemphigoid. An immunohistochemical analysis

1 reference

12 December 2020

Immune-mediated subepithelial blistering diseases of mucous membranes. Pure ocular cicatricial pemphigoid is a unique clinical and immunopathological entity distinct from bullous pemphigoid and other subsets identified by antigenic specificity of au

1 reference

12 December 2020

Long-term results of systemic chemotherapy for ocular cicatricial pemphigoid

1 reference

12 December 2020

Minimizing cicatricial pemphigoid orodynia with minocycline

1 reference

12 December 2020

Cyclosporine therapy of life-threatening cicatricial pemphigoid affecting the respiratory tract

1 reference

12 December 2020

10.1016/J.CDEN.2013.07.003

Identifiers

DOI

0 references

Fatcat ID

release_3u7x6b556nalfgsctzfqbzi3hu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3u7x6b556nalfgsctzfqbzi3hu

24 November 2022